Literature DB >> 16410057

Swelling and vacuolisation of mitochondria in transgenic SOD1-ALS mice: a consequence of supranormal SOD1 expression?

Dick Jaarsma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410057     DOI: 10.1016/j.mito.2005.10.005

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


× No keyword cloud information.
  10 in total

1.  Nonamyloid aggregates arising from mature copper/zinc superoxide dismutases resemble those observed in amyotrophic lateral sclerosis.

Authors:  Young-Mi Hwang; Peter B Stathopulos; Kristin Dimmick; Hong Yang; Hamid R Badiei; Ming Sze Tong; Jessica A O Rumfeldt; Pu Chen; Vassili Karanassios; Elizabeth M Meiering
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

2.  Transcriptional profiling in the lumbar spinal cord of a mouse model of amyotrophic lateral sclerosis: a role for wild-type superoxide dismutase 1 in sporadic disease?

Authors:  Antonello D'Arrigo; Davide Colavito; Emiliano Peña-Altamira; Michele Fabris; Mauro Dam; Antonio Contestabile; Alberta Leon
Journal:  J Mol Neurosci       Date:  2010-02-23       Impact factor: 3.444

3.  Nuclear localization of human SOD1 and mutant SOD1-specific disruption of survival motor neuron protein complex in transgenic amyotrophic lateral sclerosis mice.

Authors:  Barry Gertz; Margaret Wong; Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2012-02       Impact factor: 3.685

Review 4.  TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology.

Authors:  Iga Wegorzewska; Robert H Baloh
Journal:  Neurodegener Dis       Date:  2010-12-03       Impact factor: 2.977

5.  The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice.

Authors:  Lee J Martin; Barry Gertz; Yan Pan; Ann C Price; Jeffery D Molkentin; Qing Chang
Journal:  Exp Neurol       Date:  2009-03-09       Impact factor: 5.330

6.  Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization.

Authors:  Ryuji Yamaguchi; Lydia Lartigue; Guy Perkins; Ray T Scott; Amruta Dixit; Yulia Kushnareva; Tomomi Kuwana; Mark H Ellisman; Donald D Newmeyer
Journal:  Mol Cell       Date:  2008-08-07       Impact factor: 17.970

Review 7.  The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.

Authors:  Lee J Martin
Journal:  Biochim Biophys Acta       Date:  2009-08-03

Review 8.  SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.

Authors:  Peter I Joyce; Pietro Fratta; Elizabeth M C Fisher; Abraham Acevedo-Arozena
Journal:  Mamm Genome       Date:  2011-06-26       Impact factor: 2.957

9.  Age-dependent degeneration of an identified adult leg motor neuron in a Drosophila SOD1 model of ALS.

Authors:  Anthony Agudelo; Victoria St Amand; Lindsey Grissom; Danielle Lafond; Toni Achilli; Asli Sahin; Robert Reenan; Geoff Stilwell
Journal:  Biol Open       Date:  2020-10-21       Impact factor: 2.422

10.  Therapeutic Treatment of Superoxide Dismutase 1 (G93A) Amyotrophic Lateral Sclerosis Model Mice with Medical Ozone Decelerates Trigeminal Motor Neuron Degeneration, Attenuates Microglial Proliferation, and Preserves Monocyte Levels in Mesenteric Lymph Nodes.

Authors:  Michael Bette; Eileen Cors; Carolin Kresse; Burkhard Schütz
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.